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INTRODUCTION: Testing for in vitro 
cytotoxicity aims at obtaining data for a test 
material from simplified in vitro systems that can 
be used to make a prognosis for a key step within 
the processes occurring after implantation in the 
human body. Depending on the application of the 
test specimens, one can choose from a number of 
different assays to assess its bioacceptance in 
terms of absence of cytotoxicity. While guidelines 
(e.g. ISO, ASTM) describe a number of mandatory 
test procedures for official approval, additional 
tests have to be performed to properly evaluate the 
in vitro effects of test specimen on cells. However, 
in most cases it is difficult to select the appropriate 
assay. In addition, the conclusions that can be 
made out of the results are often limited 1. They 
give trends rather than enable clear-cut 
recommendations. In this work we evaluate for the 
bioacceptance of different Ti alloys by two 
different assays; the agar overlay test and the 
extraction test, both described by the ISO 10993-5 
guidelines. Opportunities and limits of cytotoxicity 
testing based on these and other methods will be 
discussed.  
METHODS: Various Ti alloy samples were 
prepared by powder injection moulding. Sintered 
parts were sterilized by autoclaving or hydrogen 
peroxide gas plasma. The agar overlay test as well 
as the extraction tests were performed according to 
the ISO 10993-5 guideline. In case of the agar 
overlay test cells were vitally labelled using 
neutral red before use. After 24, 48 and 72 h of 
treatment toxicity was assessed taking the size of 
the zone without cells as an index. In case of the 
extract test cytotoxicity was assessed after 24h of 
treatment using neutral red and MTT (or WST-8) 
assays. From the obtained extracts the ions were 
quantified by ICP-EOS. 
RESULTS: Large differences in outcome were 
obtained by evaluating the titanium alloys using 
agar overlay and extract tests with the agar overlay 
test being most sensitive. Only in the case of the 
agar overlay, the test cells were strongly affected 
by the samples after 24h. Basically, no such toxic 
effect could be observed using the extract test after 
the same treatment period.  
DISCUSSION & CONCLUSIONS: Titanium is 
a widely used FDA approved implant material and 
passed all officially required in vitro as well as in 
vivo tests. Nevertheless, controversial data are 
reported (and also found in our lab) regarding the 
cytotoxic effects of Ti (alloy) materials (from no 
to moderate cytotoxicity). This was seen not only 
for the different alloys but also for the different 
cell assays, which most likely resulted from 
differences in preparation methods of the 
specimens and cell assay set-ups used.  
The ISO 10993-5 extract test norm is rather 
flexible regarding extract medium, extraction 
method, treatment period and method to quantify 
cytotoxicity. As a result the outcome of different 
labs cannot be compared.  The indirect extract test 
(which the overlay test in principle represents) in 
contrast is less prone to variations in experimental 
set-up. Furthermore, it might mimic better the 
local concentrations of the released constituents 
occurring in vivo in the tissue being in direct 
contact with the implant. In our hands this test 
showed to be most sensitive. 
Thus while generally in vitro cytotoxicity testing 
represents a great opportunity to pre-evaluate the 
influence on cells regarding the released 
constituents of the test material,  a careful, well 
documented and broad evaluation of assays is 
required in order to get an overall clear-cut 
impression concerning this key issue of 
bioacceptance. 
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